Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M W Konstan

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Clinics in Chest Medicine|October 6, 1998
Therapies aimed at airway inflammation in cystic fibrosisM W Konstan
Current Opinion in Pulmonary Medicine|November 1, 1996
Treatment of airway inflammation in cystic fibrosisM W Konstan
Pediatric Pulmonology|August 1, 1997
Current understanding of the inflammatory process in cystic fibrosis: onset and etiologyM W Konstan, M Berger
The Journal of Allergy and Clinical Immunology|July 10, 1999
Altered respiratory epithelial cell cytokine production in cystic fibrosisT L Bonfield, M W Konstan, M Berger
American Journal of Respiratory and Critical Care Medicine|November 1, 1996
Cystic fibrosisP B Davis, M Drumm, M W Konstan
Pediatric Research|February 1, 1997
Identifying treatments that halt progression of pulmonary disease in cystic fibrosisP B Davis, P J Byard, M W Konstan
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 2, 2023
Longitudinal bacterial prevalence in cystic fibrosis airways: Fact and artifactD R VanDevanter, J J LiPuma, M W Konstan
Experimental Lung Research|May 1, 1982
A comparative study of lysozyme and its secretion by tracheal epitheliumM W Konstan, P W Cheng, T F Boat
The American Review of Respiratory Disease|January 1, 1990
Ibuprofen attenuates the inflammatory response to Pseudomonas aeruginosa in a rat model of chronic pulmonary infection. Implications for antiinflammatory therapy in cystic fibrosisM W Konstan, K M Vargo, P B Davis
Chest|April 20, 1999
The use of anti-inflammatory medications in cystic fibrosis: trends and physician attitudesC M Oermann, M M Sockrider, M W Konstan
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Clinics in Chest Medicine|October 6, 1998
Therapies aimed at airway inflammation in cystic fibrosisM W Konstan
Current Opinion in Pulmonary Medicine|November 1, 1996
Treatment of airway inflammation in cystic fibrosisM W Konstan
Pediatric Pulmonology|August 1, 1997
Current understanding of the inflammatory process in cystic fibrosis: onset and etiologyM W Konstan, M Berger
The Journal of Allergy and Clinical Immunology|July 10, 1999
Altered respiratory epithelial cell cytokine production in cystic fibrosisT L Bonfield, M W Konstan, M Berger
American Journal of Respiratory and Critical Care Medicine|November 1, 1996
Cystic fibrosisP B Davis, M Drumm, M W Konstan
Pediatric Research|February 1, 1997
Identifying treatments that halt progression of pulmonary disease in cystic fibrosisP B Davis, P J Byard, M W Konstan
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 2, 2023
Longitudinal bacterial prevalence in cystic fibrosis airways: Fact and artifactD R VanDevanter, J J LiPuma, M W Konstan
Experimental Lung Research|May 1, 1982
A comparative study of lysozyme and its secretion by tracheal epitheliumM W Konstan, P W Cheng, T F Boat
The American Review of Respiratory Disease|January 1, 1990
Ibuprofen attenuates the inflammatory response to Pseudomonas aeruginosa in a rat model of chronic pulmonary infection. Implications for antiinflammatory therapy in cystic fibrosisM W Konstan, K M Vargo, P B Davis
Chest|April 20, 1999
The use of anti-inflammatory medications in cystic fibrosis: trends and physician attitudesC M Oermann, M M Sockrider, M W Konstan
Pageof 5